Observational studyThe oncologist2022

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.

Saima Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.